A detailed history of Creative Planning transactions in Royalty Pharma PLC stock. As of the latest transaction made, Creative Planning holds 19,911 shares of RPRX stock, worth $483,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,911
Previous 19,990 0.4%
Holding current value
$483,439
Previous $527,000 6.83%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$25.63 - $29.27 $2,024 - $2,312
-79 Reduced 0.4%
19,911 $563,000
Q2 2024

Aug 15, 2024

SELL
$26.26 - $29.9 $449,860 - $512,216
-17,131 Reduced 46.15%
19,990 $527,000
Q1 2024

May 10, 2024

BUY
$27.46 - $31.33 $37,675 - $42,984
1,372 Added 3.84%
37,121 $1.13 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $332,421 - $370,597
12,683 Added 54.99%
35,749 $1 Million
Q3 2023

Nov 16, 2023

BUY
$26.26 - $31.38 $605,713 - $723,811
23,066 New
23,066 $626,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.